ReviewAnnals of the rheumatic diseases2005
Update on rituximab.
Review in Annals of the rheumatic diseases, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis.Arthritis research & therapy · 2006Trial
- Article
- Review
- Timing of COVID-19 Vaccine in the Setting of Anti-CD20 Therapy: A Primer for Nephrologists.Kidney international reports · 2021Article
- Analytical similarity assessment of rituximab biosimilar CT-P10 to reference medicinal product.mAbs · 2018Article
- Cerebral toxoplasmosis in a diffuse large B cell lymphoma patient.Radiology and oncology · 2016Article
- Recent advances in the field of anti-cancer immunotherapy.BBA clinical · 2015Review
- The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/cfs).Molecular neurobiology · 2014Review
- Experience with rituximab in the treatment of antineutrophil cytoplasmic antibody associated vasculitis.Therapeutic advances in musculoskeletal disease · 2014Review
- Review
- Translational Mini-Review Series on B Cell-Directed Therapies: B cell-directed therapy for autoimmune diseases.Clinical and experimental immunology · 2009Review
- Article
- Rapidly fatal Acanthamoeba encephalitis and treatment of cryoglobulinemia.Emerging infectious diseases · 2007Article
- Immunotherapy for Graves' orbitopathy: easy enthusiasm, but let's keep trying.Journal of endocrinological investigation · 2006Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.